FIDELIO study: significance and place of finerenone as nonsteroidal mineralocorticoid receptor antagonist in therapy of patients with chronic kidney disease in type 2 diabetes by M. S. Shamkhalova, O. Yu. Sukhareva, M. I. Yevloyeva

Get full text

Canagliflozin: from glycemic control to improvement of cardiovascular and renal prognosis in patients with type 2 diabetes mellitus. Resolution of Advisory Board by M. V. Shestakova, A. S. Ametov, M. B. Antsiferov, T. P. Bardymova, F. V. Valeeva, G. R. Galstyan, T. Yu. Demidova, I. A. Karpova, T. P. Kiseleva, A. Yu. Mayorov, A. M. Mkrtumyan, S. V. Nedogoda, N. А. Petunina, L. A. Ruyatkina, L. A. Suplotova, O. Yu. Sukhareva, V. V. Fadeev, M. S. Shamkhalova

Get full text

Cardiovascular prevention 2022. Russian national guidelines by S. A. Boytsov, N. V. Pogosova, A. A. Ansheles, V. A. Badtieva, T. V. Balakhonova, O. L. Barbarash, Yu. A. Vasyuk, N. G. Gambaryan, G. E. Gendlin, S. P. Golitsyn, O. M. Drapkina, L. Yu. Drozdova, M. V. Yezhov, A. I. Ershova, I. V. Zhirov, Yu. A. Karpov, Zh. D. Kobalava, A. V. Kontsevaya, A. Yu. Litvin, M. M. Lukyanov, S. Yu. Martsevich, S. T. Matskeplishvili, V. A. Metelskaya, A. N. Meshkov, I. E. Mishina, E. P. Panchenko, A. B. Popova, I. V. Sergienko, M. D. Smirnova, M. I. Smirnova, O. Yu. Sokolova, A. V. Starodubova, O. Yu. Sukhareva, S. K. Ternovoy, O. N. Tkacheva, S. A. Shalnova, M. V. Shestakova

Get full text